Half of lymphoma patients alive three years after Gilead cell therapy treatment: study - SABC News - Breaking news, special reports, world, business, sport coverage of all South African current events. Africa's news leader.

  • 📰 SABC News Online
  • ⏱ Reading Time:
  • 35 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 17%
  • Publisher: 51%

Malaysia News News

Malaysia Malaysia Latest News,Malaysia Malaysia Headlines

Half of lymphoma patients alive three years after Gilead cell therapy treatment: study

Out of 101 patients teated with Yescarta for an aggressive blood cancer known as refractory large B-cell lymphoma in the study, 47 were still alive at least three years later, the data presented at the American Society of Hematology meeting in Orlando showed.

Sales of Yescarta, which won U.S. approval in October 2017 and carries a list price of $373,000, were slow to take off due to a range of issues, including high hospital costs and a complicated manufacturing process. Yescarta belongs to a new class of cancer treatments called CAR-T therapy, seen as potentially revolutionary due to their promise of long-term survival with a one-time treatment for certain deadly blood cancers, such as relapsed or refractory large B-cell lymphomas.

Yescarta competes with Kymriah from Novartis AG, while several companies also are developing CAR-T treatments, including some that aim to be off-the-shelf rather than patient specific.

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 32. in MY
 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.

Malaysia Malaysia Latest News, Malaysia Malaysia Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

WATCH LIVE: State Capture Inquiry - SABC News - Breaking news, special reports, world, business, sport coverage of all South African current events. Africa's news leader.The hearings of the Commission of Inquiry into State Capture continue in Parktown, Johannesburg.
Source: SABC News Online - 🏆 32. / 51 Read more »

CSA suspends its CEO - SABC News - Breaking news, special reports, world, business, sport coverage of all South African current events. Africa's news leader.Cricket South Africa CEO Thabang Moroe has been suspended. This follows news that Standard Bank will not renew its agreement with CSA as the title sponsor of the South African National Men's Cricket Team when it concludes on 30 April 2020.
Source: SABC News Online - 🏆 32. / 51 Read more »

Anele Hoyana’s funeral under way - SABC News - Breaking news, special reports, world, business, sport coverage of all South African current events. Africa's news leader.Forty-year-old Anele Hoyana is being buried in East London on Saturday.
Source: SABC News Online - 🏆 32. / 51 Read more »

Load shedding continues on Saturday - SABC News - Breaking news, special reports, world, business, sport coverage of all South African current events. Africa's news leader.Eskom says it has made some progress in reducing unplanned breakdowns but stage 2 load shedding will continue until 11pm Saturday. I curse the day anc took over power in South Africa, 1994 promised to be the beginning of greater things to come, but boy, the whole thing has blown up in our faces and turned out to be a real NIGHTMARE, God, what did we let ourselves into!!!👃🙏
Source: SABC News Online - 🏆 32. / 51 Read more »

Miners trapped in Orkney - SABC News - Breaking news, special reports, world, business, sport coverage of all South African current events. Africa's news leader.A systemic tremor at the Orkney mine, Tau Lefa, near Klerksdorp in North West has left five people trapped underground. Tjho Safety at mines is still a challenge government please do something Thina cela lapa nkulunkulu yena siza bona lapa kalo skati lo. Futi mina temba bona zphuma bona sindile, yena mubi sterek lo kuvaleleka lapa mgodi
Source: SABC News Online - 🏆 32. / 51 Read more »